Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice
- 25 February 2004
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 96 (1), 135-148
- https://doi.org/10.1016/j.jconrel.2004.01.010
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Micellar Nanocontainers Distribute to Defined Cytoplasmic OrganellesScience, 2003
- Incorporation and Release of Hydrophobic Probes in Biocompatible Polycaprolactone-block-poly(ethylene oxide) Micelles: Implications for Drug DeliveryLangmuir, 2002
- Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(ε-caprolactone) as novel anticancer drug carriersBiomaterials, 2001
- Physicochemical Evaluation of Nanoparticles Assembled from Poly(lactic acid)−Poly(ethylene glycol) (PLA−PEG) Block Copolymers as Drug Delivery VehiclesLangmuir, 2001
- Self-Assembly of Poly(caprolactone-b-ethylene oxide-b-caprolactone) via a Microphase Inversion in WaterThe Journal of Physical Chemistry B, 2001
- Nano-engineering block copolymer aggregates for drug deliveryColloids and Surfaces B: Biointerfaces, 1999
- Alkyl Esters of Camptothecin and 9-Nitrocamptothecin: Synthesis, in Vitro Pharmacokinetics, Toxicity, and Antitumor ActivityJournal of Medicinal Chemistry, 1998
- Biodegradable Long-Circulating Polymeric NanospheresScience, 1994
- Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly (ethylene oxide-aspartate) block copolymer-adriamycin conjugatesJournal of Controlled Release, 1994
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966